ERBB3 Back

v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of ERBB3

This gene encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases. This membrane-bound protein has a neuregulin binding domain but not an active kinase domain. It therefore can bind this ligand but not convey the signal into the cell through protein phosphorylation. However, it does form heterodimers with other EGF receptor family members which do have kinase activity. Heterodimerization leads to the activation of pathways which lead to cell proliferation or differentiation. Amplification of this gene and/or overexpression of its protein have been reported in numerous cancers, including prostate, bladder, and breast tumors. Alternate transcriptional splice variants encoding different isoforms have been characterized. One isoform lacks the intermembrane region and is secreted outside the cell. This form acts to modulate the activity of the membrane-bound form. Additional splice variants have also been reported, but they have not been thoroughly characterized.

Community Annotation of ERBB3 Add / Edit ERBB3: Annotations

No community annotations yet for ERBB3.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes

• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


ERBB3 is highly significantly mutated in
17 patients (6%)
combined cohort
90 patients (1%)
ERBB3 is significantly mutated in
10 patients (10%)
14 patients (6%)
ERBB3 is near significance in
13 patients (1%)

Click on a tumor type to see its full list of significant genes.

Data details

Mutation list for ERBB3